Roxatidine
Roxatidine used in the management of peptic ulcer disease.
Primary Characteristics
It belongs to Piperidine.
It belongs to H2-antagonist pharmacological group on the basis of mechanism of action.
Molecular Weight: 384.9 · Solubility in Water: null · Solubility in Alcohol: null · Non-proprietary name: Roxatidine.

Pharmacokinetics
Elimination: renal excretion is 90 %.
Advertisement
Indications
Roxatidine is primarily indicated in conditions like GI ulceration, Hyperacidity.
Roxatidine is also indicated for secondary conditions like Reflux oesophagitis.
Contraindications
Roxatidine is contraindicated in conditions like Anuria.
Dosage
Roxatidine's dosage details are as follows:
| Dose | Single Dose | Frequency | Route | Instructions |
|---|---|---|---|---|
| Adult Dosage | ||||
| 112.5 mg | 112.5 mg | Every 24h | PO | |
| Paediatric Dosage (20kg) | ||||
| 0 – 0 | — | — | Not recommended in this age group | |
| Neonatal Dosage (3kg) | ||||
| No data. | ||||
Drug Interactions
None recorded.
Side Effects
Roxatidine is known to cause more or less tolerable side effects which are usually transient. These include Constipation , Diarrhea, Dizziness, Headache, Nausea and vomiting, Restlessness, Skin rashes.
Warnings / Precautions
Interference in Pathology
Roxatidine may interfere in the diagnosis of Increased hepatic enzyme concentrations..
Available Brands
Storage Conditions
Drug Classification
- 1.17.1.2 — Anti-peptic ulcerants
Manufacturers
Manufacturers of Roxatidine in Pakistan: